# Insulin Degludec

NDC: 73070-403
Generic name: insulin degludec
Labeler / Manufacturer: Novo Nordisk Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20220701

FDA application: BLA203314

## Active ingredients

- INSULIN DEGLUDEC: 100 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73070-403"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73070-403
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1be283d-4b1d-4996-b2a7-4488dbff3037